Research programme: cannabidiol conjugated skin disorder therapeutics - Diverse Biotech/Enveric Biosciences
Alternative Names: CBD-conjugated skin disorder therapeutics - Diverse Biotech/Enveric BiosciencesLatest Information Update: 08 Apr 2021
At a glance
- Originator Diverse Biotech
- Developer Enveric Biosciences
- Class Anti-inflammatories; Cannabinoids; Cyclohexenes; Drug conjugates; Skin disorder therapies; Small molecules
- Mechanism of Action 5-HT1 serotonin receptor modulators; Cannabinoid receptor CB1 inverse agonists; Cannabinoid receptor CB2 inverse agonists; Transient receptor potential channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Skin disorders